Publications

About
Programs
Placements
Contact

Welcome message

Faculty Members

Publications

  1. Sakthi Priyadarsini Sethuraman, Kumar PR. (2024). Phytochemical Profiling, In-vitro Antioxidant and Cytotoxic Effects of Luisia tenuifolia Extracts Against Human Skin Squamous Carcinoma. Applied biochemistry and biotechnology,  2024;196(1):400-416.doi:10.1007/s12010-023-04521-https://doi.org/10.1007/s12010-023-04521-x (Impact factor-3.01)
  2. Sowmiya Velemurugan, Sakthi Priyadarsini Sethuraman* and Raju Kamaraj (2024). In-vitro Antioxidant and Cytotoxic Effects of Physalis minima Linn. in HeLa Cell Lines Against Cervical Cancer. Current Trends in Biotechnology and  Pharmacy Vol. 18(1) 1582-1586.
  3. Sudheer Kumar, Raju Kamaraj (2023) Compliance challenges in clinical research organizations: A USFDA inspection retrospective. J Pharm Pharmacogn Res 12(1): 91- 98. https://doi.org/10.56499/jppres23.1782_12.1.91
  4. Sudheer Kumar , Kamaraj R. A Retrospective Study of Documentation Shortfalls Mentioned in USFDA Warning Letters Issued to India Pharmaceutical Industries. International Journal of Pharmaceutical  Quality Assurance. 2023;14(4):1067-1070. 10.25258/ijpqa.14.4.39
  5. Kamaraj R, Shankar Ganesh K (2023) COMPARATIVE REGULATORY ASPECTS ON NUTRACEUTICALS IN INDIA, JAPAN, EUROPE international Journal of Biology, Pharmacy and Allied Sciences (2023)  12(10): 4626-4640  https://doi.org/10.31032/IJBPAS/2023/12.10.7482
  6. Kamaraj R, J Rashi (2023) European Union Good Pharmacovigilance Practice (Good Safety Communication) 2023, 12(10): 4670-4684 https://doi.org/10.31032/IJBPAS/2023/12.10.7489
  7. Tamil Azhagan V , MANIMARAN V* AND KAMARAJ R (2023) Regulatory Requirement And Structural Framework For Nutraceuticals And Functional Foods In European Union 2023, 12(10): 4685-4697  https://doi.org/10.31032/IJBPAS/2023/12.10.749
  8. Kamaraj R, Kavya SM (2023) A Review Article on Drug Price Control Order Implementations, Impacts and Flaws, International Journal of Biology, Pharmacy and Allied Sciences 2023, 12(7): 3268-3284  https://doi.org/10.31032/IJBPAS/2023/12.7.7288
  9. Kamaraj R, Praveen TS (2023) European Union Good Pharmacovigilance Practice (Risk Management Plan) International Journal of Biology, Pharmacy and Allied Sciences 2023 12(7): 3392- 3407 https://doi.org/10.31032/IJBPAS/2023/12.7.7316
  10. Priyanka VR, Kamaraj R (2023) Applications of Artificial Intelligence in Pharmaceutical Industry, International Journal of Biology, Pharmacy and Allied Sciences 2023, 12(4): 1820-1828  https://doi.org/10.31032/IJBPAS/2023/12.4.7080
  11. Tanmai v, Kamaraj R (2023) A Review on the nda 505(b)(1) and NDA 505(b)(2) regulatory paths for new drug products and their regulatory implications from the USFDA, International Journal of Biology,  Pharmacy and Allied Sciences 2023, 12(2): 669-681https://doi.org/10.31032/IJBPAS/2023/12.2.6835
  12. Sreenu Thalla, Kamaraj R, Kavitha A (2023) A Prospective Observational Study on Clinical Spectrum of Hepatitis C Patients in the Gastroenterology Department of a Tertiary Care Hospital, Eur. Chem.  Bull. 2023,12(5), 1360-1367 Doi: 10.48047/ecb/2023.12.5.094
  13. Overview on Medicinal Plants in the Treatment of Cardio Vascular Diseases Illness Kashif Ahamed S, Thirumal M* and Kumar P R, IJBPAS, February, 2023, 12(2): 805- 816. https://doi.org/10.31032/IJBPAS/2023/12.2.6863
  14. Shibin R, Sakthi Priyadarsini.S, Kamaraj R. (2023) In silico herbal informatic approach for identification of medicinal plants targeting Staphylococcus aureus, International journal of Pharmacy and biological Sciences 12(10); 461-471.
  15. Ramya, M, Kamaraj, R, Shalini, K. (2023). “Overview, Pathogenesis and Medicinal plant used for Treatment of Vitiligo”. Journal of Chemical Health Risks. 13(4s), 1015 -1020. 
  16. Muralidharan, S.P, Kamaraj, R, Shalini, K. (2023). “Review Article on Neutraceuticals”. Journal of Chemical Health Risks”. 13(4s), 1006 -1014. 17. Kamaraj R, Gopika m , Sonia k (2023) Types of Variations in Europe – Variation Filing Procedure and Overview 2022, 11(12): 5823-5841  https://doi.org/10.31032/IJBPAS/2022/11.12.6650
  17. Jyothika Thuyamani, Raju Kamaraj. (2022) Overview of regulatory systems and technology for tracking counterfeit, adulterated and sub stranded medications with the recommendation in Indian regulatory systems Neuroquantology volume 20 issue 12 page 916-924 doi:  10.14704/nq.2022.20.12. nq77073.
  18. Dineshkumar M, Kamaraj R (2022) Impact of The Conflict Between Russia and Ukraine on The Pharmaceutical Industry and Disruption in India. Neuroquantology Volume 20 Issue 17 Page 341-345 Doi:  10.14704/Nq.2022.20.17. Nq88047.
  19. Subhadarshini Bhagyashree, R Kamaraj (2022) Evaluating the hatch waxman amendment’s influence on FDA’s generic medication approval process. Journal of Pharmaceutical Negative Results Volume 13 Special Issue 6 DOI: https://doi.org/10.47750/pnr.2022.13.S06.45
  20. R Kamaraj, Archana Panerai, Dr. Abimanyu Sugumaran. (2022) Marketing Authorization of Medical Device De Novo For USFDA. Neuroquantology Volume 20 Issue 17 Page 365-371 Doi:  10.14704/Nq.2022.20.17. Nq88050.
  21. Praveen Kumar S, R Kamaraj. (2022) Compliance with Regulatory Requirements and Their Implementation Regarding the Storing and Distribution of Pharmaceuticals In India, Us And EU. Neuroquantology, Volume 20 Issue 17 Page 390-398 Doi: 10.14704/Nq.2022.20.17.  Nq88053.
  1. Nanbban R, R Kamaraj. (2022) Herbal Product Regulation and Development in India. Neuroquantology, Volume 20 Issue 17 Page 381- 389 Doi: 10.14704/Nq.2022.20.17. Nq88052
  2. Kamaraj R, Panga Yamini. (2022) Current Pharmaceutical Regulations of United Kingdom: Post Brexit. Journal of Pharmaceutical Negative Results Volume 13 Special Issue 6 DOI:10.47750/pnr.2022.13. S06.455
  3. Raju Kamaraj, T.Sudheer Kumar (2022) A Cross- Sectional Analysis of Data Integrity Related USFDA Warning Letters To Improve Compliance Status. Journal of Pharmaceutical Negative Results: Volume 13, Special  Issue 9. DOI: https://doi.org/10.47750/pnr.2022.13.S09.276
  4. Sreenu Thalla Kamaraj, (2022) A. Kavitha Impact of Diabetes with Nonalcoholic Fatty Liver Disease in Gastroenterology Department of Tertiary Care Hospital – A Prospective Cross-Sectional Study Journal of  Pharmaceutical Negative Results Volume 13 Special Issue 9 4045-4051.  DOI: https://doi.org/10.47750/pnr.2022.13.S09.499
  5. Sreenu Thalla Kamaraj, A. Kavitha (2022) A Prospective Observational Study on Prevalence of Diabetes with Nonalcoholic Fatty Liver Disease in Gastroenterology Department of Tertiary Care Hospital Neuro  Quantology Volume 20 Issue 9 Page 5459-5458 doi:  10.14704/nq.2022.20.9. NQ44638
  6. Sreenu Thalla, Kamaraj R and Kavitha A. (2022) Increasing Risk Factors for Non- Alcoholic Fatty Liver Disease; an Insight into Chronic Periodontotis and Insulin Resistance. Endocrine, Metabolic & Immune  Disorders- Drug Target. Volume 22, Issue 8, 807- 814. DOI:  10.2174/1871530322666220104095534
  7. R. kamaraj, T. Sudheer Kumar. (2022) Retrospective Analysis of USFDA Warning letters against cGMP Violations in Indian pharmaceutical Industries. NeuroQuantology; 20(6) :6958-6954.DOI:  10.14704/nq.2022.20.6.NQ22701
  1. R. Kamaraj and T. Sudheer. (2022) Cross- Sectional Analysis of Investigation Failures cited in USFDA Warning Letters and its Impact on Indian Pharmaceutical Industries. Eur. Chem.Bull.2022,11 (4), 50-54.  DOI- 10.31838/ech/2022.11.11.04.007.
  2. Bharathi Mohan, Kamaraj and K. Navyaja. (2022) Role of Artificial Intelligence in Parenteral Formulation; A Review. ECS Trans 107 20049 DOI 10.1149/10701.20013ecst
  3. Navya, R. kamaraj and M. Bharathi. (2022) The Trending Role of Artificial Intelligence and its Applications in Formulation of Solid Dosage Forms. A: Review ECS Transections Volume 107, 1, 20049- 20055 DOI 10.1149/10701.20049ecst
  4. N.T Vikram, R. Illavarasan and R. Kamaraj. (2022) Anti-Cancer activities of schedule E1 drugs used in ayurvedic formulations. Journal of Ayurveda and Integrative Medicine 13(2022) 100545. doi:  10.1016/j.jaim.2022.100545
  5. Abimanyu Sugumaran, Ramya Ravichandran, Kamaraj Raju, (2022) Role of regulatory agencies on covid-19 waste management. J. Med. P’ceutical Allied Sci. V 11 – I 1, Pages – 4455 – 4459 doi:  10.22270/jmpas. V11I1.2477.
  6. Raju Kamaraj, Nandini Pasam, (2022) Regulation & registration of drugs and biologics in Brazil. J. Med. P’ceutical Allied Sci. V 11 – I 1, Pages – 4332 – 4339 doi: 10.55522/jmpas. V11I1.2158
  7. Effect of Increased Blood Viscosity in Human Beings. An Overview Praveen S, Thirumal M* and Kumar P R, IJBPAS, December, 2022, 11(12): 5678- 5688. https://doi.org/10.31032/IJBPAS/2022/11.12.6625
  8. Nilavembu Kudineer (Siddha Polyherbal Decoction) for the Management of COVID-19–Evidences from Clinical and In-silico NMP Maideen Indian Journal of Integrative Medicine
  9. Phytoconstituents Screening, TLC, And GC-MS Analysis of Barleria Cristata Leaves Methanolic Extract. Journal of Pharmaceutical Negative Results, V Harini, PR Kumar, M Thirumal, 4445- 4450. https://doi.org/10.47750/pnr.2022.13.S08.569
  10. Identification Of Bioactive Phytochemicals By GC-MS Profiling, Phytochemical Screening, And TLC Using Methanolic Extract Of Carissa Carandas Linn Leaf. Journal of Pharmaceutical Negative Results, S Monika, M Thirumal, PR Kumar, 4439-4444. https://doi.org/10.47750/pnr.2022.13.S08.568
  11. An Insight of Clinical Evidence of Ayurveda Interventions in the Management of COVID-19 Patients, Infectious Disorders-Drug Targets, NMP Maideen, R Balasubramanian, G Manavalan, K Balasubramanian.
  12. Potential of Urai mathirai (pediatric siddha formulation) for the prophylaxis and management of covid-19 in children NMP Maideen, G Manavalan, K Balasubramanian, S Nivedhitha, Asian Journal of Advances in Medical Science, 147-158.
  13. An update of COVID-19 pandemic in India, Kumudhaveni B, Thirumal M, Health Science Reports 4 (3), 1-3.
  14. Sakthi Priyadarsini, Vijayalakshmi Palanisami, Gopika Madhusoodanan, B. Velavan, A. M. Yusuf and P. R. Kumar. In VitroCytotoxic activity of Rhinacanthin Enriched Extract from Leaves of Rhinacanthus nasutus (L.) Kurz., (Acanthaceae) against Neuroblastoma Cell Line. Indian Journal of Pharmaceutical Sciences. Indian J Pharm Sci 2022;84(5):1197-1202.
  15. Sakthi Priyadarsini S, Kumar PR. Evaluation of Hydrogen peroxide scavenging and antibacterial activity of successive extracts of Luisia tenuifolia Blume against skin and wound infections. Research Journal of Pharmacy and Technology.  2022;15(10):4565-4569.
  16. Shalini, K and Ilango, K. (2022). “Macroscopical and microscopical analysis of selected Indian medicinal plants and HPTLC method for quantification of chemical markers in a polyherbal formulation”. Journal of Pharmacy &  Pharmacognosy Research. 10(2), 253-269.
  17. Shalini, K, Chitra. V and Ilango, K. (2022). “Selected Indian Medicinal Plants for Mitigating Polycystic Ovarian Syndrome: A Review”. Rasayan Journal of Chemistry. 15(2), 894-906.
  18. Sooria S, Raju Kamaraj, Sonia karuppaiah. (2021) Regulatory Filing of Generic drug in Europe. International journal of Pharmaceutical Research, Vol 13 issue 2. DOI:  https://doi.org/10.31838/ijpr/2021.13.02.351
  19. Meghana Jiji Johnson, Raju Kamaraj. (2021) Impact of Warning Letters on Indian and United States Based Pharmaceutical Industries: Cause and Effect Analysis. International journal of Pharmaceutical Research  Vol 13 issue 2. DOI: https://doi.org/10.31838/ijpr/2021.13.02.341.
  20. Krishna K, Raju Kamaraj. (2021) Roadmap of European Union Pharmacovigilance requirements on European Medicines Agency. International journal of Pharmaceutical Research Vol 13 issue 2. DOI: https://doi.org/10.31838/ijpr/2021.13.02.341.
  21. Arunkumar P, Raju Kamaraj, kavitha, Uma Maheshwari. (2021) Challenges in Pharmaceutical Product Life Cycle Management. International journal of Pharmaceutical Research. Vol 13 issue 2. DOI:  https://doi.org/10.31838/ijpr/2021.13.02.349.
  22. Anandh S, Raju Kamaraj, Abimanyu Sugumaran. (2021) Challenges and Prospects for Filing Certificate of Suitability in Europe. International journal of Pharmaceutical Research;Vol 13 issue 2. DOI:  https://doi.org/10.31838/ijpr/2021.13.02.350.
  23. Vijaykumar CS, Abimanyu Sugumaran, Raju kamaraj. (2021) Nutraceuticals in India. International journal of Pharmaceutical Research, Vol 13 issue 2. DOI:  https://doi.org/10.31838/ijpr/2021.13.02.383.
  24. Shermilan P.A, Raju Kamaraj. (2021) ANDA Submissions – Refuse to Receive (RTR). Standards and Deficiencies of CTD modules in ANDA. International journal of Pharmaceutical Research, Vol 13 issue 2. .DOI:  https://doi.org/10.31838/ijpr/2021.13.02.350.
  25. Kamaraj R, Gopika M and Sonia.K. (2021) Types of Variationsin Europe- Variation Filing Procedure and Overview.IJBPAS, 11(12): 5823- 5841. DOI: https://doi.org/10.31032/IJBPAS/2022/11.12.6650.
  26. Sakthi Priyadarsini S, Kumar PR. Coumarins in Orchidaceae: a Review connecting Ethnomedicine and therapeutic expectations. Rasayan J Chem. 2021;14(4):2591-2597.
  27. Sakthi Priyadarsini S, Kumar PR. Chemical Profiling of Volatile Bioactives in Luisia tenuifolia Blume Successive Extracts by GC-MS Analysis. Appl Biochem Biotechnol. 2022; 194(1):84-98. doi: 10.1007/s12010-021-03745-z.  (Impact factor-3.1)
  28. Sakthi Priyadarsini S, Kumar PR. Pharmacognostical standardisation of an epiphytic orchid, Luisia tenuifolia J Pharm Pharmacog Res, 2022;10:113-127. (Impact factor-1.5)
  29. Sakthi Priyadarsini S, Mohana Priya G, Ramya R, Lavanya S and Kumar PR. Preliminary phytochemical screening, thin layer chromatography profiling, and in vitro antiurolithiatic activity of the leaves of Ravenala madagascariensis Indian Journal of Natural Products and Resources, 2021, 12, 425-430.
  30. Shalini, K and Ilango, K. (2021). “Development, Evaluation and RP-HPLC method for Simultaneous Estimation of Quercetin, Ellagic acid and Kaempferol in Polyherbal Formulation”. International Journal of Applied Pharmaceutics. 13 (3):  183-192..
  31. Shalini, K and Ilango, K. (2021). “Preliminary Phytochemical Studies, GC-MS Analysis and In vitro Antioxidant Activity of Selected Medicinal Plants and its Polyherbal Formulation”. Pharmacognosy Journal. 13(3): 648-659. 
  32. Pralesha sahoo, & Raju Kamaraj (2020). Review of Data Integrity in Pharmaceutical Industry. Int.J.Res.Pharm.sci, 11(SPL4), 1323-1328. DOI: https://doi.org/10.26452/ijrps.v11iSPL4.4300.
  33. Uma Maheshwari A, & Raju Kamaraj (2020). Regulatory Approval process for marketing drug in Japan.Int.J.Res.Sci 12(2), 1081-1085 DOI:https://doi.org/10.26452/ijrps.v10i4
  34. Ramireddy Navya Sri, Kamaraj R, & Sonia K. (2020). Regulatory aspects of GMP in accordance with pharmaceutical inspection co-operation scheme. Int.J.Res.Sci 11(SPL4), 1333-1340. Ajithkumar S, Raju kamaraj.  Marketing Registration of Herbal Products in European Union.  International journal of Pharmaceutical Research –. DOI:  https://doi.org/10.26452/ijrps.v10i3.
  1. Lokesh C, Sonia K, Raju Kamaraj. (2020) Regulatory Requirements for Biological product Approval process in India. Res J Pharm Tech. 13(2):1050-1054. DOI: 10.5958/0974-360X.2020.00193.6
  2. Poovarasan D, Manikandan K, Raju Kamaraj R. (2020) Regulatory Requirement and Registration Process of Generic Drugs in Japan. Res J Pharm Tech. 13(3):1523-1526. DOI: 10.5958/0974-360X.2020.00277.
  3. Aravindan N, Seetharaman, Raju Kamaraj (2020) Change Control in Pharmaceutical Quality Management System. Res J Pharm Tech ; 13(4):1987-1990. DOI: 10.5958/0974-360X.2020.00357.1
  4. Rajashekar S, Rajukamaraj, Abimanyu S. (2020) Risk and Opportunities in Development of New Drug. Research J. Pharm. and Tech 2020; 13(6): 3041 -3044. DOI: 10.5958/0974-360X.2020.00537.5
  5. Satheesh S, S Abimanyu, Kamaraj (2020). Regulatory Challenges of Sterile Formulation Development as Per USFDA Prospectives. Research J. Pharm. and Tech. 13(3): 1511-1516. DOI: 10.5958/0974- 360X.2020.00275.9
  6. Jimson Zachariah. C, Raju Kamaraj (2020) Regulatory Drug Approval Process in Canada. Res J Pharm Tech. 13(4):2040-2044. DOI: 10.5958/0974-360X.2020.00367.4
  7. Sathyanarayanan AS, Lakshmi KS, Raju Kamaraj. (2020) An Overview on Good Pharmacovigilance Practices and New Operational. Res J Pharm Tech; 13(4): 1795-1800. DOI: 10.5958/0974- 360X.2020.00323.6
  8. Janarthanan S, Kamaraj Raju. (2020) Medical device regulation in U.S. Res J Pharm Tech; 13(9): 4453-4456. DOI: 10.5958/0974- 360X.2020.00786.6
  9. Dhatchanamoorthi N, Raju Kamaraj. (2020) An overview on challenges and importance of computer system validation in pharmaceutical industry. Res J Pharm Tech; 13(11):5591-5594. DOI: 10.5958/0974- 360X.2020.00975.0
  10. Sakthi Priyadarsini S, Vani PB, Kumar PR. A Comparative Review on Conventional and Traditional medicine in the Treatment of Psoriasis. Res J Pharm Tech. 2020;13 (11): 5642-5646.
  11. Sakthi Priyadarsini S, Vani PB, Abdhul Kareem A, Janani R, Kumar PR. Antitumor effect of leaves of Ravenala madagascariensis Sonn., in PANC1 and SW1990 pancreatic cell lines. Ind J nat prod res. 2020; 11 (2):89-95.
  12. Sakthi Priyadarsini S, Kumar PR, Abhishek Anand, Devendiran B, Venkat SK, Richie PR. Insulin Secretagogue Effect Of Roots Of Ravenala Madagascariensis – An In Vitro Study. Asian J Pharm Clin Res, 2020. 12(2), 1-4.
  13. Annamalai maduram, and Raju Kamaraj. (2019) To study the in vitro inhibition of blood platelet aggregation by isolated compounds from clausena dentata (willd.) roem. Asian J. Pharm.Clin Res. 12(12): 128- 133. DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i12.35557
  14. Annamalai maduram, and Raju Kamaraj. (2019) To study the antibacterial activity of various extracts of clausena dentata (willd.) roem. Asian J. Pharm.Clin Res.; 13(1): 69-73. doi.org/10.22159/ajpcr.  2019.v13i1.35553
  15. Holarrhena antidysenterica Linn.–A Review G Gopinath, M Thirumal, PR Kumar Research Journal of Pharmacy and Technology 13 (4), 2013-2018
  16. Raju Kamaraj and Annamalai Maduram (2018) Analgesic and Anti inflammatory activity of various extracts of clausena dentate (Willd.) Roem. Asian J Pharm Clin Res.11(2): 413-416. DOI: http://dx.doi.org/10.22159/aipcr.2018. V11i2.23681.
  17. Raju Kamaraj, Linda M Buruwe. (2018) Comparative study of Regulatory Requirements and marketing Authorization for Medicinal Products in European Union and Zimbabwe. Asian J. Pharm.Clin Res;  11(10): 1-8. http://dx.doi.org/10.22159/aipcr.2018. V11i10.26837.
  18. Umar Khan, Kamaraj R, (2018) A review on the centralised registration procedure in the gulf cooperation council (GCC) region”, Res J Pharm Tech.; 11(12):5653-5668. DOI: 10.5958/0974-360X.2018.01025.9
  19. Vetri Priya, Kamaraj R (2018) An invasive launch of two compendiums: orange book and purplebook by FDA. 11(7): 3617-3623. DOI: 10.5958/0974-360X.2018.00666.2
  20. Vasa Lakshmi Shravanthi, Kamaraj R, (2018) Regulatory labelling requirements and its labelling comparison between US and EU. Res J Pharm Tech. 2018; 11(11): 4875-4877. DOI: 10.5958/0974- 360X.2018.00887.9
  21. Subaranjani, Kamaraj R (2018) Food facility registration US-FDA” Res J Pharm Tech. 11(10): 4744-4748. DOI: 10.5958/0974- 360X.2018.00864.8
  22. Janani, Manikandan, Kamaraj R (2018) “Overview of biosimilars” Res J Pharm Tech 11(11): 5152-5158. DOI: 10.5958/0974- 360X.2018.00941.1.
  23. Bhavyashree, Manikandan, Kamaraj R (2018) “Marketing approval of medical device in European union” Res J Pharm Tech. 11(1):391-395. DOI: 10.5958/0974-360X.2019.00071.4
  24. Mishma Jaasu, Seetharaman, Kamaraj R, (2018) “A review on medical dictionary for regulatory activities (MedDRA)”, Res J Pharm Tech. 11(10): 4751-4754. DOI: 10.5958/0974-360X.2018.00866.1
  25. Santhosh S, Kamaraj. 510(k) Premarket Notification.(2018) Research J. Pharm. and Tech 2018; 11(12): 5675-5780. doi: 10.5958/0974- 360X.2018.01028.4
  26. Sakthi Priyadarsini S, Kumar PR, Thirumal M. Formulation and evaluation of a herbal antibacterial cream from ethylacetate extract of leaves of Spinacia oleracea, against Aeromonas skin and soft tissue infections., Int J Green Pharm, July-Sep  2018 (Suppl), 12 (3),S537-42. doi.org/10.22377/ijgp.v12i03.2015
  27. Raju kamaraj, Manokaran Manju. (2017) Biosimilar current status in India, Asian JPharmClinRes.10(1):25-28 DOI: https://doi.org/10.22159/ajpcr.2017.v10i1.14814
  28. Raju Kamaraj,Annamalai Maduram and N. Raaman. (2017) Hepatoprotective activity of various extracts of clausena dentate (Willd.) Roem. Asian J Pharm Clin Res, 2017; 10(10): 310-313. DOI:  https://doi.org/10.22159/ajpcr.2017.v10i10.20127
  29. Nitric Oxide Radical Scavenging activity of the Ethanolic and Chloroform extracts of Ocimum basilicum – A comparative Study. Research Journal of Pharmacognosy and Phytochemistry. 2017; 9(4) Oct – Dec, 215-218. Kumar PR, Sakthi  Priyadarsini S, Thirumal M.
  30. Anticancer Potential of Indian Medicinal Plants – A Review. International Journal of Pharmacy and Biological Sciences. 2017; 7(4) Oct – Dec, 128-132. Kumar PR, Sakthi Priyadarsini S, Thirumal M, Musenda TJ.
  31. Kumar PR, Sakthi Priyadarsini S, Thirumal M. Anticancer potential of Indian medicinal plants- A review. International Journal of Pharmacy and Biological Sciences. 2017;7(4),2017 :128-132.
  32. Kumar PR, Sakthi Priyadarsini S, Thirumal M. Nitric Oxide Radical Scavenging activity of the Ethanolic and Chloroform extracts of Ocimum basilicum Leaves – A Comparative Study. Res J Pharmacogn Phytochem. 2017;9(4):215-218.
  33. Sukasini S, Bhargav Iyer M, Sakthi Priyadarsini S, Kumar PR. Retrospect of Ormocarpum sennoides (willd.) Dc: A boon to Phytomedicine, Global J Res. Med. Plants & Indigen. Med, 2015;4(10):203–208.
  34. Sakthi Priyadarsini S, Kumar PR, Thirumal M, Joseph Blessing A, Prabhu P, Vyshnavi P. Antibacterial Effect of Successive Extracts of Leaves of Spinacia oleracea Linn., Am. J. PharmTech Res. 2015; 5(5):223-230.
  35. Kumar PR, Vijayalakshmi A, Sakthi Priyadarsini S, Mounika Arava. Development and Evaluation of Topical Formulation with Chloroform Extract of Pisonia grandis leaves for Anti inflammatory effect, Int J ChemTech Research,  2014; 6(5):2660-2667.
  36. Vijayalakshmi A, Kumar PR, Sakthi Priyadarsini S. Pharmacognostical and phytochemical evaluation of root bark of Plumaria acutifolia, J Pharmacogn Phytochem, 2014;2(6):13-17.
  37. Vijayalakshmi A, Kumar PR, Sakthi Priyadarsini S, Meenakshi C. Pharmacognostical and phytochemical investigation of the aerial parts of Cissus quadrangularis Journal of Scientific and Innovative Res. 2013;2(5):872-879.
  38. Vijayalakshmi A, Kumar PR, Sakthi Priyadarsini S. Pharmacognostical and phytochemical evaluation of Givotia rottleriformis. J Pharmacogn Phytochem. 2013;2(3):113-19.
  39. Sakthi Priyadarsini S, Vadivu R, Vijayalakshmi A, Kumar PR, Antioxidant activity of Ravenala madagascariensis, leaves on alloxan induced diabetic rats. Int J PharmTech Res. 2013; 5(4): 1823-1827.
  40. Vijayalakshmi A, Kumar PR, Sakthi Priyadarsini S. Invitro Antioxidant and Anticancer activity of flavonoid fraction from the aerial parts of Cissus quadrangularis Against Human Breast Carcinoma Cell Lines. Journal of Chemistry. 2013,1-9.

SRM Faculty of Management Welcomes Freshers for the New Academic Year

Institutional Renaissance through Industrial Research

Art from Waste: Circuit to Canvas Mural Challenge

Clay Modelling Workshop at SRMIST

Agri Startup 2.0 at SRMIST: A Step Toward Sustainable Agriculture and National Prosperity

SRMIST Celebrates 79th Independence Day

View More News
No data was found
View More Events

Testimonials

No data was found
Alumni Connect

Contact us

Publications

Icon-facebook Twitter Icon-instagram-1 Youtube Linkedin Globe-africa